Related Experiment Video
Updated: Aug 9, 2026

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
CD8 T-cell recognition of human 5T4 oncofetal antigen
Lucy J C Smyth1, Eyad Elkord, Taher E I Taher
1Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, United Kingdom.
Abstract:
The 5T4 oncofetal antigen is expressed by a wide variety of human carcinomas, including colorectal, ovarian and gastric carcinomas. The restricted expression of 5T4 on tumor tissues as well as its implication in tumor progression and bad prognosis makes 5T4 a promising new candidate for immunotherapy. An MVA vaccine encoding 5T4 antigen has been successfully evaluated in preclinical studies in a murine tumor model. Here, we report the generation of human CD8 T cells specific for the 5T4 antigen by stimulation with autologous monocyte derived DC infected with a replication defective adenovirus encoding the 5T4 cDNA (Ad5T4). Analysis of several donors confirms a repertoire of such CD8 responses. In a parallel approach, incorporating the results of proteasome-mediated digestion of 5T4 derived 35-mer peptides and the potential high affinity epitopes predicted by a computer-based algorithm, we identified 8 putative HLA-A*0201-presented CD8 MHC class I epitopes of 5T4 antigen. Two of these generated specific CD8 T cells after restimulation with peptide loaded autologous DC and assay by cytotoxicity and IFN gamma ELISPOT. Moreover these particular peptide generated T cells recognized naturally 5T4 positive tumor cells only if they expressed HLA-A*0201 as judged by IFN gamma ELISPOT or ELISA. Also, HLA-A*0201 CD8 T cells recognized these peptides in a DC-Ad5T4 polyclonal response. In conclusion, there is a repertoire of CD8 T cell recognition of 5T4 in normal human donors and some candidate HLA-A*0201 epitopes have been identified.
Insights
Researchers generated human CD8 T cells targeting the 5T4 oncofetal antigen for cancer immunotherapy. They identified specific HLA-A*0201 epitopes that recognize 5T4-positive tumor cells, offering a promising avenue for therapeutic development.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- The 5T4 oncofetal antigen is prevalent in various human carcinomas, indicating its potential as a target for cancer immunotherapy.
- Previous preclinical studies showed success with an MVA vaccine encoding the 5T4 antigen in a murine model.
Purpose of the Study:
- To generate human CD8 T cells specific for the 5T4 antigen.
- To identify potential HLA-A*0201-presented epitopes of the 5T4 antigen for targeted immunotherapy.
Main Methods:
- Human CD8 T cells were generated by stimulating autologous monocyte-derived dendritic cells (DCs) with a replication-defective adenovirus encoding the 5T4 cDNA (Ad5T4).
- Epitopes were identified using proteasome digestion of peptides and computational prediction algorithms.
- T cell responses were assessed via cytotoxicity assays, IFN-gamma ELISPOT, and ELISA, with recognition of tumor cells evaluated based on HLA-A*0201 expression.
Main Results:
- A repertoire of CD8 T cell responses specific to the 5T4 antigen was confirmed across multiple donors.
- Eight putative HLA-A*0201-presented CD8 MHC class I epitopes of the 5T4 antigen were identified.
- Two epitopes successfully generated specific CD8 T cells that recognized naturally 5T4-positive tumor cells expressing HLA-A*0201.
Conclusions:
- There is a natural repertoire of CD8 T cell recognition of the 5T4 antigen in healthy individuals.
- Candidate HLA-A*0201 epitopes of 5T4 have been identified, paving the way for the development of targeted immunotherapies against 5T4-expressing carcinomas.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

